Global Blood Screening Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Blood Screening Market to foresee a significant growth in the industry over the upcoming years. The global blood screening market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global blood screening market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this blood screening market.

The next sections of the blood screening market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Technology

Nucleic Acid Amplification Test (NAT)
ELISA
Chemiluminescence Immunoassay (CLIA)
Enzyme Immunoassay (EIA)
Next-Generation Sequencing (NGS)
Western Blotting

By Product

Reagent
Instrument

Product Code: VMR11210532

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Blood Screening Market
2.2. Global Blood Screening Market Snapshot

3 . BLOOD SCREENING - INDUSTRY ANALYSIS

3.1. Introduction
3.2. Market Drivers of Blood Screening Market
3.3. Market Restraints of Blood Screening Market
3.4. Opportunities of Blood Screening Market
3.5. Trends of Blood Screening Market
3.6. Porter's Five Force Analysis of Blood Screening Market
3.7. Blood Screening Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Technology
- 3.7.2 Market Attractive Analysis by Product
- 3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

4.1. Blood Screening Value Chain Analysis
4.2. Blood Screening Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Blood Screening Raw Material Manufactures List
- 4.2.3. Price Trend of Blood Screening Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BLOOD SCREENING MARKET ANALYSIS BY TECHNOLOGY

5.1 Overview by Technology
5.2 Global Blood Screening Market Analysis by Technology
5.3 Market Analysis of Nucleic Acid Amplification Test (NAT) by Regions
5.4 Market Analysis of ELISA by Regions
5.5 Market Analysis of Chemiluminescence Immunoassay (CLIA) by Regions
5.6 Market Analysis of Enzyme Immunoassay (EIA) by Regions
5.7 Market Analysis of Next-Generation Sequencing (NGS) by Regions
5.8 Market Analysis of Western Blotting by Regions

6 . GLOBAL BLOOD SCREENING MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Global Blood Screening Market Analysis by Product
6.3 Market Analysis of Reagent by Regions
6.4 Market Analysis of Instrument by Regions

7 . GLOBAL BLOOD SCREENING MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America
- 7.3.1. Overview
- 7.3.2. North America Blood Screening Market Estimate by Market Segment
- 7.3.3. North America Blood Screening Market Estimate by Country
- 7.3.4. United State
- 7.3.5. Rest of North America
7.4. Europe
- 7.4.1. Overview
- 7.4.2. Europe Blood Screening Market Estimate by Market Segment
- 7.4.3. Europe Blood Screening Market Estimate by Country
- 7.4.4. United Kingdom
- 7.4.5. France
- 7.4.6. Germany
- 7.4.7 Rest of Europe
7.5. Asia Pacific
- 7.5.1. Overview
- 7.5.2. Asia Pacific Blood Screening Market Estimate by Market Segment
- 7.5.3. Asia Pacific Blood Screening Market Estimate by Country
- 7.5.4. China
- 7.5.5. Japan
- 7.5.6. India
- 7.5.7. Rest of Asia Pacific
7.6. Latin America
- 7.6.1. Overview
- 7.6.2. Latin America Blood Screening Market Estimate by Market Segment
- 7.6.3. Latin America Blood Screening Market Estimate by Country
- 7.6.4. Brazil
- 7.6.5. Rest of Latin America
7.7. Middle East & Africa
- 7.7.1. Overview
- 7.7.2. Middle East & Africa Blood Screening Market Estimate by Market Segment
- 7.7.3. Middle East & Africa Blood Screening Market Estimate by Country
- 7.7.4. Middle East
- 7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE BLOOD SCREENING COMPANIES

8.1. Blood Screening Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF BLOOD SCREENING INDUSTRY

9.1. Company Share Analysis
9.2. Market Concentration Rate
9.3. Abbott Laboratories
- 9.3.1. Company Overview
- 9.3.2. Financials
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Becton Dickinson and Company
- 9.4.1. Company Overview
- 9.4.2. Financials
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Bio-Rad Laboratories, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financials
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Danaher Corporation
- 9.6.1. Company Overview
- 9.6.2. Financials
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. F. Hoffmann-La Roche Ltd.
- 9.7.1. Company Overview
- 9.7.2. Financials
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Grifols
- 9.8.1. Company Overview
- 9.8.2. Financials
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Ortho-Clinical Diagnostics, Inc.
- 9.9.1. Company Overview
- 9.9.2. Financials
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Siemens Healthcare GmbH
- 9.10.1. Company Overview
- 9.10.2. Financials
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. SOFINA s.a (Biomerieux)
- 9.11.1. Company Overview
- 9.11.2. Financials
- 9.11.3. Products
- 9.11.4. Recent Developments
9.12. Thermo Fisher Scientific, Inc.
- 9.12.1. Company Overview
- 9.12.2. Financials
- 9.12.3. Products
- 9.12.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK

10.1. Impact Analysis of Covid-19 Outbreak on the Market
- 10.1.1. Direct Impact on Production
- 10.1.2. Supply Chain and Market Disruption
- 10.1.3. Financial Impact on Firms and Financial Markets
10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
10.3. Pre V/S Post COVID-19 Market
10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
10.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies